-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ni9/tdE/WyLiEM+GXz7HrZvN0Jhts0aU+iBIOMaPdPmiLN1PXPyAEnN++UOzNMa9 2U8lzximhHU3vJgUY44DpA== 0001354457-09-000220.txt : 20090728 0001354457-09-000220.hdr.sgml : 20090728 20090728095458 ACCESSION NUMBER: 0001354457-09-000220 CONFORMED SUBMISSION TYPE: 25-NSE CONFIRMING COPY: PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20090728 DATE AS OF CHANGE: 20090728 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NASDAQ Stock Market LLC CENTRAL INDEX KEY: 0001354457 IRS NUMBER: 521165937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: 9600 BLACKWELL RD CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-978-4144 MAIL ADDRESS: STREET 1: 9600 BLACKWELL RD CITY: ROCKVILLE STATE: MD ZIP: 20850 25-NSE 1 primary_doc.xml X0203 0001354457 NASDAQ Stock Market LLC 0000356830 OSCIENT PHARMACEUTICALS CORP 000-10824
100 Beaver Street Waltham MA MASSACHUSETTS 02154
617-398-2300 Common Stock 17 CFR 240.12d2-2(b) Amy Horton Associate General Counsel 2009-07-28 EX-99.25 2 oscidelistreason.txt Delisting Determination,The Nasdaq Stock Market, LLC, July 28, 2009, Oscient Pharmaceuticals Corporation. The Nasdaq Stock Market, Inc. (the Exchange) has determined to remove from listing the common stock of Oscient Pharmaceuticals Corporation (the Company), effective at the opening of the trading session on August 7, 2009. Based on a review of the information provided by the Company, Nasdaq Staff determined that the Company no longer qualified for listing on the Exchange pursuant to Listing Rules 5210(d), 5100, 5110(b) and IM-5100-1. The Company was notified of the Staffs determinations on July 10, 2009 and July 14, 2009. The Company did not appeal the Staff determinations to the Hearings Panel, and the Staff determination to delist the Company became final on July 21, 2009. -----END PRIVACY-ENHANCED MESSAGE-----